Synavant Sells Pharmaceutical DM Unit

Share this article:
The French firm Groupe Cegedim purchased the direct marketing arm of Atlanta-based pharmaceutical marketer Synavant for $43.5 million, the companies said Sunday.


Synavant said it decided that its direct marketing business unit was no longer part of its core business strategy. The DM unit generated $50 million in revenue in the 12 months ending in September 2002.


Proceeds of the sales will be given to shareholders, Synavant said, though the form of the transfer has yet to be decided. Synavant also said it would review its other business units and decide whether to invest more resources in them or consider other transactions.


The purchase expands Groupe Cegedim's presence in North America. Groupe Cegedim also specializes in pharmaceutical marketing.


Share this article:

Sign up to our newsletters

Follow us on Twitter @dmnews

Latest Jobs:

More in News

Target Names Retail Veteran Brian Cornell as CEO

Target Names Retail Veteran Brian Cornell as CEO

He leaves the top job at PepsiCo Foods to take the spot vacated by Greg Steinhafel in the aftermath of the data breach.

NBA Names Insurance Exec as its CMO

NBA Names Insurance Exec as its CMO

Nationwide and State Farm veteran Pamela El takes the league's marketing helm next month.

Bloomberg Names Bigley CMO

Bloomberg Names Bigley CMO

Communications chief Deirdre Bigley is appointed head of global marketing for the business and financial news company.